| Bioactivity | PACAP (6-27) (human, ovine, rat) is a PACAP receptor antagonist that blocks the canine adrenal catecholamine response to exogenous vasoactive intestinal peptide (VIP). PACAP (6-27) (human, ovine, rat) has the potential to study cardiovascular and neurological diseases[1]. |
| Target | PACAP receptor. |
| Name | PACAP (6-27) (human, ovine, rat) |
| CAS | 136134-68-4 |
| Sequence | Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2 |
| Shortening | FTDSYSRYRKQMAVKKYLAAVL-NH2 |
| Formula | C121H193N33O31S |
| Molar Mass | 2638.09 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gaspo R, et al. Canine adrenal catecholamine response to VIP is blocked by PACAP-(6-27) in vivo. Am J Physiol. 1997 May;272(5 Pt 2):R1606-12. |
PACAP (6-27) (human, ovine, rat)
CAS: 136134-68-4 F: C121H193N33O31S W: 2638.09
PACAP (6-27) (human, ovine, rat) is a PACAP receptor antagonist that blocks the canine adrenal catecholamine response to
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.